# Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

> **NCT00080938** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 26 (actual)

## Conditions studied

- Lung Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** Temozolomide
- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT00080938
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12-20
- **Primary completion:** 2008-08
- **Final completion:** 2009-02
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00080938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00080938, "Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00080938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*